Bypass gástrico versus BAGUA en el tratamiento de la obesidad y la diabetes: revisión sistemática

Abstract

Title: Gastric Bypass versus BAGUA in Treating Obesity and Diabetes: A Systematic Review Objective: Which procedure is more beneficial between Gastric Bypass and BAGUA for treating obesity and diabetes? Methodology: PRISMA criteria were followed, including studies in English published between 2019 and 2024 in open-access Q1-Q4 journals. Comparative studies of RYGB and BAGUA in obesity and diabetes were analyzed, excluding clinical guidelines, meta-analyses, theses, and revision surgery studies. The databases were PubMed, Scopus, and Cochrane. Bias was assessed with RoB 2 for randomized studies and the Newcastle-Ottawa Scale for observational studies. Data were analyzed using Excel 2019. Results: Ten studies showed that BAGUA offers advantages in quality of life, operative time, and postoperative nausea compared to RYGB. BAGUA also demonstrated significantly greater weight loss and a slight, although not significant, advantage in diabetes remission. Discussion: Limitations include bias due to small sample sizes and restrictions to open-access articles. Although there are conflicting studies, most indicate that BAGUA is more beneficial, with fewer adverse effects and better outcomes in weight loss and diabetes remission. Conclusions: BAGUA is superior to RYGB in treating obesity and type 2 diabetes, offering more significant benefits, fewer complications, better mid- and long-term weight loss, and a favorable trend in type 2 diabetes remission